North American Neuroendocrine Tumor Society shared on LinkedIn:
“Today is NET Cancer Day, and it falls just days after the 2026 NANETS Annual Symposium in Las Vegas.
The timing feels fitting. Last week, clinicians, researchers, allied health professionals, trainees and more, from across the world came together for three days of learning, discussion, and collaboration focused on neuroendocrine tumors.
From new research presented through our call for abstracts to conversations that carried into the hallways, the energy reflected a community committed to better outcomes for NET patients.
Thank you to our program chair, Dr. Menna Haider, and co-chair, Dr. Chandrikha Chandrasekharan, along with our faculty, abstract presenters, sponsors, patient organizations, and every attendee who made this year’s meeting such a success.
On NET Cancer Day, we’re reminded why this work matters.
Every advance in NET diagnosis, treatment, and supportive care begins with professionals who choose to learn, share, and push the field forward.
We hope to see you in Scottsdale, October 28–30, 2027.”
Other articles about NANETS on OncoDaily.
